JOYCE STRATMOEN: Open Payments
NPI 1841736170 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 28 payments from 7 companies in 2025. Trend: 2023 $89 · 2024 $400 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $224 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| Travere Therapeutics, Inc. | 5 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| Novo Nordisk Inc | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Vifor Pharma, Inc. | 1 | $26 |
Products named: Kerendia, JARDIANCE, FARXIGA, Veltassa, Rybelsus, Ozempic.
Industry payments across AR — which companies pay providers there.
